Stefania Douka, Vasilis Papamoschou, Monica Raimo, Enrico Mastrobattista, & Massimiliano Caiazzo. (2024). Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy. MDPI AG.
Chicago-čujuhus (17. p.)Stefania Douka, Vasilis Papamoschou, Monica Raimo, Enrico Mastrobattista, juo Massimiliano Caiazzo. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy. MDPI AG, 2024.
MLA-čujuhus (9. p.)Stefania Douka, et al. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy. MDPI AG, 2024.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.